Therapeutic potential of fetal mesenchymal stem cells

Current Stem Cell Research and Therapy

Volumn 8, Issue 2, 2013, Pages 115-116

  Roubelakis, Maria G ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; AMNION FLUID; AMNIOTIC FLUID CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CELL HOMING; CELL ISOLATION; EDITORIAL; FETAL STEM CELL; GENETIC MANIPULATION; HUMAN; MEDICAL ETHICS; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; UMBILICAL CORD; UMBILICAL CORD BLOOD;

ANIMALS; DISEASE MODELS, ANIMAL; FETAL STEM CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS;

EID: 84875585659     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X11308020001     Document Type: Editorial

References (12)

1. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-650.
2. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974; 17: 331-340.
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
4. Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22: 625-634.
5. In't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548-1549.
6. Roubelakis MG, Bitsika V, Zagoura D, et al. In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells. J Cell Mol Med 2011; 15: 1896-1913.
7. Roubelakis MG, Pappa KI, Bitsika V, et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev 2007; 16: 931-952.
8. De Coppi P, Bartsch G, Jr., Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-106.
9. Abdulrazzak H, Moschidou D, Jones G, Guillot PV. Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues. J R Soc Interface 2010; 7 Suppl 6: S689-706.
10. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the developmental continuum? Regen Med 2009; 4: 423-433.
11. Roubelakis MG, Trohatou O, Anagnou NP. Amniotic fluid and amniotic membrane stem cells: marker discovery. Stem Cells Int 2012; 2012: 107836.
12. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.